相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Involvement of Oxygen-regulated Protein 150 in AMP-activated Protein Kinase-mediated Alleviation of Lipid-induced Endoplasmic Reticulum Stress
Yun Wang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Influence of the flavonoids apigenin, kaempferol, and quercetin on the function of organic anion transporting polypeptides 1A2 and 2B1
Kathrin Mandery et al.
BIOCHEMICAL PHARMACOLOGY (2010)
Functional Characterization of Mouse Organic Anion Transporting Peptide 1a4 in the Uptake and Efflux of Drugs Across the Blood-Brain Barrier
Atsushi Ose et al.
DRUG METABOLISM AND DISPOSITION (2010)
Drug efficiency: a new concept to guide lead optimization programs towards the selection of better clinical candidates
Simone Braggio et al.
EXPERT OPINION ON DRUG DISCOVERY (2010)
Does sumatriptan cross the blood-brain barrier in animals and man?
Peer Carsten Tfelt-Hansen
JOURNAL OF HEADACHE AND PAIN (2010)
Membrane transporters in drug development
Kathleen M. Giacomini et al.
NATURE REVIEWS DRUG DISCOVERY (2010)
Impact of OATP transporters on pharmacokinetics
A. Kalliokoski et al.
BRITISH JOURNAL OF PHARMACOLOGY (2009)
The Effect of Breast Cancer Resistance Protein and P-Glycoprotein on the Brain Penetration of Flavopiridol, Imatinib Mesylate (Gleevec), Prazosin, and 2-Methoxy-3-(4-(2-(5-methyl-2-phenyloxazol-4-yl)ethoxy)phenyl)propanoic Acid (PF-407288) in Mice
Lin Zhou et al.
DRUG METABOLISM AND DISPOSITION (2009)
Pharmacogenetics of the organic anion transporting polypeptide 1A2
Ryan M. Franke et al.
PHARMACOGENOMICS (2009)
Quantitative investigation of the role of breast cancer resistance protein (Bcrp/Abcg2) in limiting brain and testis penetration of xenobiotic compounds
Junichi Enokizono et al.
DRUG METABOLISM AND DISPOSITION (2008)
Sumatriptan normalizes the migraine attack-related increase in brain serotonin synthesis
Y. Sakai et al.
NEUROLOGY (2008)
Multidrug and toxic compound extrusion (MATE)-type proteins as anchor transporters for the excretion of metabolic waste products and xenobiotics
Y. Moriyama et al.
XENOBIOTICA (2008)
Central nervous system drug disposition: The relationship between in situ brain permeability and brain free fraction
Scott G. Summerfield et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2007)
Intestinal drug transporter expression and the impact of grapefruit juice in humans
H. Glaeser et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2007)
Interaction of methotrexate with organic-anion transporting polypeptide 1A2 and its genetic variants
Ilaria Badagnani et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2006)
In vitro P-glycoprotein inhibition assays for assessment of clinical drug interaction potential of new drug candidates: A recommendation for probe substrates
J Rautio et al.
DRUG METABOLISM AND DISPOSITION (2006)
Blood-brain barrier penetration of zolmitriptan -: Modelling of positron emission tomography data
M Bergström et al.
JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS (2006)
BacMam recombinant baculovirus in transporter expression: A study of BCRP and OATP1B1
Namir J. Hassan et al.
PROTEIN EXPRESSION AND PURIFICATION (2006)
ABCC drug efflux pumps and organic anion uptake transporters in human gliomas and the blood-tumor barrier
H Bronger et al.
CANCER RESEARCH (2005)
Polymorphisms in human organic anion-transporting polypeptide 1A2 (OATP1A2) - Implications for altered drug disposition and central nervous system drug entry
W Lee et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Evaluation of the MDR-MDCK cell line as a permeability screen for the blood-brain barrier
Q Wang et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2005)
Characterization of GhRac1 GTPase expressed in developing cotton (Gossypium hirsutum L.) fibers
HJ Kim et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENE STRUCTURE AND EXPRESSION (2004)
Eletriptan metabolism by human hepatic CYP450 enzymes and transport by human P-glycoprotein
DC Evans et al.
DRUG METABOLISM AND DISPOSITION (2003)
分享论文
